Marseille, 9 october 2026 – Aix-Marseille Université, the coordinating institution of the Marseille Immunology Biocluster (MIB) consortium, has joined France Biotech. This membership will enable MIB to take part in national discussions on the development of healthcare innovation companies and strengthen its ties with organisations across the sector. France Biotech is an independent association bringing […]
SAB Voices: Erika Pearce – Reprogramming Immunity Through Metabolism
Marseille, 29 September 2026 – Prof. Erika Pearce still remembers when immunology began to feel less like a subject and more like a revelation. As a third-year undergraduate student, she enrolled in an immunology course with little prior exposure to the field beyond the everyday encounters most people have with medicine, such as doctor visits […]
Why autoimmune diseases are the next frontier of immunology
Marseille, September 27, 2026 – For decades, patients with autoimmune diseases were expected to manage them for life. Treatments improved and symptoms could be controlled for many, but eliminating the disease remained largely out of reach. In recent years, that expectation has been shifting. There has been tremendous progress done to keep autoimmune diseases at […]
SAB Voices: Jean-Daniel Lelièvre Thinks Everyone Does Immunology Without Knowing It
Marseille, 13 August 2026 – Prof. Jean-Daniel Lelièvre, a member of Marseille Immunology Biocluster’s Scientific Advisory Board, didn’t initially imagine a life in medicine. He came from a family of artists, with a father, grandfather and brother trained at the Beaux-Arts, and once considered an artistic path himself. Medicine came later, first through an interest […]
MIB Startup Studio launches its first call for applications to support immunology startups
Marseille, 6 July 2026 – Marseille Immunology Biocluster has launched the first call for applications for MIB Startup Studio, an initiative designed to support immunology startups in their scientific, strategic and entrepreneurial development. Created to support high-potential projects, MIB Startup Studio is aimed at established startups seeking to accelerate their development by connecting with a […]
MIB joins France BioLead to strengthen France’s biomanufacturing ecosystem for biomedicines
Marseille, July 2026 – Marseille Immunology Biocluster has become a member of France BioLead, the national accelerator and representative of France’s biomanufacturing ecosystem for biomedicines. This membership marks an important step in MIB’s commitment to strengthening a sovereign, innovative and collaborative healthcare ecosystem in France. It places the biocluster within a national momentum aimed at […]
SAB Voices: Francesca Barone on Bringing an Entrepreneurial Mindset to Immunology
Marseille, 4 May 2026 – The first time Francesca Barone sat in a Boston café and overheard people around her discussing flow cytometry and the latest scientific discoveries, she felt she was exactly where she was meant to be. “I am a nerd at heart, so if I can do research and learn new things, […]
NANOLOGIC x Cell-Scale: Engineering Precision CAR-T for Solid Tumors
Marseille, April 14 2026 – Interview with Rémi Lasserre, Inserm Researcher at CRCM Marseille. At the Cancer Research Center of Marseille (CRCM), Inserm researcher Rémi Lasserre focuses on lymphocytes and how they can be engineered into powerful therapeutic tools. He is currently collaborating with the Cell-Scale platform, within MIB, to develop next-generation CAR-T cells designed […]
The Beacon Installed on the B-SCREEN Platform at IHU Méditerranée Infection
Accelerating innovation in infectious diseases requires building strong bridges between patient-derived samples, cutting-edge research, and therapeutic development. Marseille, March 9, 2026 – After more than six months of collective effort, the Beacon™ technology is now installed on the B-SCREEN platform within IHU Méditerranée Infection in Marseille. This milestone marks a significant step forward in establishing […]
CRISTO 2026: a new scientific meeting dedicated to translational immunology
CRISTO 2026 On April 10, 2026, the first edition of CRISTO (Clinical Research Interfaces with Translational Objectives) will take place at the Palais du Pharo in Marseille. Led by: the Clinical Investigation Centre (CIC U1409) and jointly organized by: l’Assistance Publique – Hôpitaux de Marseille (AP-HM), Marseille Immunology Biocluster, Aix-Marseille Université, and Inserm CRISTO aims to […]